Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Receivables (2022 - 2023)

Updated

Mereo BioPharma's Receivables was $9.88 million in Q2 2023.

Analysis

Mereo BioPharma (MREO) Receivables (2022 - 2023) Analysis & Trends

At the end of FY2022, Receivables at Mereo BioPharma came in at $1.36 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Mereo BioPharma 46.45 Mn -103.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 9.96 Mn
Dec 31, 2022 1.40 Mn
API Access

Mereo BioPharma Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=MREO&period=max&api_key=YOUR_API_KEY